arrow
返回
J

Jacob Lalezari

quest clinical research

57H指数
196论文数
1.4W被引数
收录论文 74
发表时间
Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b studyBudigalimab,一种抗PD-1抑制剂,用于HIV-1感染者:一项随机、安慰剂对照的1b期研究
err2025-10-15
err0
errOAAI
errMoti N. Ramgopal; Jacob P. Lalezari; Ana Gabriela Pires dos Santos; Preethi Krishnan; Tanaya R. Vaidya; Fei Zhou; Heide Betman; Patrick Dorr; Nael M. Mostafa; Maria L. Alcaide; Franco Felizarta; Jean-Pierre Routy
err分享
err收藏
A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19
err2024-11-01
err0
PREAI
errSeethamraju, Harish; Yang, Otto O.; Loftus, Richard; Ogbuagu, Onyema; Sammartino, Daniel; Mansour, Ali; Sacha, Jonah B.; Ojha, Sohita; Hansen, Scott G.; Arman, Arvin Cyrus; Lalezari, Jacob P.
err分享
err收藏
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
err2024-04-01
err1
errOAAI
errYuen, Man-Fung; Fung, Scott; Ma, Xiaoli; Nguyen, Tuan T.; Hassanein, Tarek; Hann, Hie -Won; Elkhashab, Magdy; Nahass, Ronald G.; Park, James S.; Jacobson, Ira M.; Ayoub, Walid S.; Han, Steven -Huy; Gane, Edward J.; Zomorodi, Katie; Yan, Ran; Ma, Julie; Knox, Steven J.; Stamm, Luisa M.; Bonacini, Maurizio; Weilert, Frank; Ramji, Alnoor; Bennett, Michael; Ravendhran, Natarajan; Chan, Sing; Dieterich, Douglas T.; Kwo, Paul Yien; Schiff, Eugene R.; Bae, Ho S.; Lalezari, Jacob; Agarwal, Kosh; Sulkowski, Mark S.
err分享
err收藏
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV
errAIDS
IF3.1
err2023-03-03
err3
PREAI
errSterman, Felicia L.; Lalezari, Jacob P.; Kowalczyk, Ula M.; Main, David W.; Grant, Edward M.; Caro, Luzelena; Manning, Cassie M.; Burke, Rochelle L.
err分享
err收藏
Safety and efficacy of vebicorvir administered with entecavir in treatment-naive patients with chronic hepatitis B virus infection
err2022-11-01
err25
errOAAI
errSulkowski, Mark S.; Agarwal, Kosh; Ma, Xiaoli; Nguyen, Tuan T.; Schiff, Eugene R.; Hann, Hie-Won L.; Dieterich, Douglas T.; Nahass, Ronald G.; Park, James S.; Chan, Sing; Han, Steven-Huy B.; Gane, Edward J.; Bennett, Michael; Alves, Katia; Evanchik, Marc; Yan, Ran; Huang, Qi; Lopatin, Uri; Colonno, Richard; Ma, Julie; Knox, Steven J.; Stamm, Luisa M.; Bonacini, Maurizio; Jacobson, Ira M.; Ayoub, Walid S.; Weilert, Frank; Ravendhran, Natarajan; Ramji, Alnoor; Kwo, Paul Yien; Elkhashab, Magdy; Hassanein, Tarek; Bae, Ho S.; Lalezari, Jacob P.; Fung, Scott K.; Yuen, Man-Fung
err分享
err收藏
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection
err2022-09-01
err23
PREAI
errYuen, Man-Fung; Agarwal, Kosh; Ma, Xiaoli; Nguyen, Tuan T.; Schiff, Eugene R.; Hann, Hie-Won L.; Dieterich, Douglas T.; Nahass, Ronald G.; Park, James S.; Chan, Sing; Han, Steven-Huy B.; Gane, Edward J.; Bennett, Michael; Alves, Katia; Evanchik, Marc; Yan, Ran; Huang, Qi; Lopatin, Uri; Colonno, Richard; Ma, Julie; Knox, Steven J.; Stamm, Luisa M.; Bonacini, Maurizio; Jacobson, Ira M.; Ayoub, Walid S.; Weilert, Frank; Ravendhran, Natarajan; Ramji, Alnoor; Kwo, Paul Yien; Elkhashab, Magdy; Hassanein, Tarek; Bae, Ho S.; Lalezari, Jacob P.; Fung, Scott K.; Sulkowski, Mark S.
err分享
err收藏
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species
err2022-03-31
err12
errOAAI
errChang, Xiao L.; Reed, Jason S.; Webb, Gabriela M.; Wu, Helen L.; Le, Jimmy; Bateman, Katherine B.; Greene, Justin M.; Pessoa, Cleiton; Waytashek, Courtney; Weber, Whitney C.; Hwang, Joseph; Fischer, Miranda; Moats, Cassandra; Shiel, Oriene; Bochart, Rachele M.; Crank, Hugh; Siess, Don; Giobbi, Travis; Torgerson, Jeffrey; Agnor, Rebecca; Gao, Lina; Dhody, Kush; Lalezari, Jacob P.; Bandar, Ivo Sah; Carnate, Alnor M.; Pang, Alina S.; Corley, Michael J.; Kelly, Scott; Pourhassan, Nader; Smedley, Jeremy; Bimber, Benjamin N.; Hansen, Scott G.; Ndhlovu, Lishomwa C.; Sacha, Jonah B.
err分享
err收藏
Interim safety and efficacy results of the ABI-H0731 phase 2a program exploring the combination of ABI-H0731 with Nuc therapy in treatment-naive and treatment-suppressed chronic hepatitis B patients
err2019-04-01
err21
PREAI
errMa, Xiaoli; Lalezari, Jacob; Tuan Nguyen; Bae, Ho; Schiff, Eugene R.; Fung, Scott; Yuen, Man-Fung; Hassanein, Tarek; Hann, Hie-Won; Elkhashab, Magdy; Dieterich, Douglas; Sulkowski, Mark; Kwo, Paul; Nahass, Ronald; Agarwal, Kosh; Ramji, Alnoor; Park, James; Ravendhran, Natarajan; Chan, Sing; Weilert, Frank; Han, Steven-Huy; Ayoub, Walid; Gane, Edward; Jacobson, Ira; Bennett, Michael; Huang, Qi; Yan, Ran; Huey, Vivian; Ruby, Eric; Liaw, Sandy; Colonno, Richard; Lopatin, Uri
err分享
err收藏
Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection
err2019-04-01
err114
errOAAI
errYuen, Man Fung; Gane, Edward J.; Kim, Dong Joon; Weilert, Frank; Chan, Henry Lik Yuen; Lalezari, Jacob; Hwang, Seong Gyu; Tuan Nguyen; Flores, Osvaldo; Hartman, George; Liaw, Sandy; Lenz, Oliver; Kakuda, Thomas N.; Talloen, Willem; Schwabe, Christian; Klumpp, Klaus; Brown, Nathaniel
err分享
err收藏
MAGELLAN-1, PART 2: GLECAPREVIR AND PIBRENTASVIR FOR 12 OR 16 WEEKS IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 AND PRIOR DIRECT-ACTING ANTIVIRAL TREATMENT FAILURE
err2017-04-01
err5
PREAI
errPoordad, Fred; Pol, Stanislas; Asatryan, Armen; Buti, Maria; Shaw, David R.; Hezode, Christophe; Lalezari, Jacob; Felizarta, Franco; Reindollar, Robert; Gordon, Stuart C.; Pianko, Stephen; Fried, Michael W.; Bernstein, David E.; Gallant, Joel; Lin, Chih-Wei; Lei, Yang; Ng, Teresa; Pilot-Matias, Tami; Kort, Jens; Mensa, Federico
err分享
err收藏
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
err2017-03-14
err27
errOAAI
errWyles, David; Saag, Michael; Viani, Rolando M.; Lalezari, Jacob; Adeyemi, Oluwatoyin; Bhatti, Laveeza; Khatri, Amit; King, Jennifer R.; Hu, Yiran B.; Trinh, Roger; Shulman, Nancy S.; Ruane, Peter
err分享
err收藏
MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure
err2017-01-01
err12
PREAI
errPoordad, F.; Pol, S.; Asatryan, A.; Buti, M.; Shaw, D.; Hezode, C.; Lalezari, J.; Felizarta, F.; Reindollar, R. W.; Gordon, S. C.; Pianko, S.; Fried, M. W.; Bernstein, D. E.; Gallant, J.; Lin, C. -W.; Lei, Y.; Ng, T. I.; Pilot-Matias, T.; Kort, J.; Mensa, F.
err分享
err收藏
High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis
err2016-10-01
err82
errOAAI
errGane, Edward; Poordad, Fred; Wang, Stanley; Asatryan, Armen; Kwo, Paul Y.; Lalezari, Jacob; Wyles, David L.; Hassanein, Tarek; Aguilar, Humberto; Maliakkal, Benedict; Liu, Ran; Lin, Chih-Wei; Ng, Teresa I.; Kort, Jens; Mensa, Federico J.
err分享
err收藏
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvir
err2016-06-16
err22
PREAI
errKowdley, Kris V.; Nelson, David R.; Lalezari, Jacob P.; Box, Terry; Gitlin, Norman; Poleynard, Gary; Rabinovitz, Mordechai; Ravendhran, Natarajan; Sheikh, Aasim M.; Siddique, Asma; Bhore, Rafia; Noviello, Stephanie; Rana, Khurram
err分享
err收藏
High SVR Rates With the Combination of ABT-493+ABT-530 for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 1 or 2 Infection
err2016-04-01
err1
PREAI
errPoordad, Fred; Felizarta, Franco; Wang, Stanley; Asatryan, Armen; Hassanein, Tarek I.; Aguilar, Humberto; Lalezari, Jacob; Overcash, J. Scott; Ng, Teresa; Lovell, Sandra S.; Lin, Chih-Wei; Kort, Jens; Mensa, Federico
err分享
err收藏
Safety of ABT-493 and ABT-530 Co-Administered in Patients with HCV Genotype 1-6 Infection: Results From the SURVEYOR-I and SURVEYOR-II Studies
err2016-04-01
err3
PREAI
errKwo, Paul Y.; Poordad, Fred; Porcalla, Ariel R.; Gane, Edward; Lalezari, Jacob; Wyles, David L.; Liu, Ran; Kort, Jens; Mensa, Federico
err分享
err收藏
100% Svr4 and Favorable Safety of Abt-493+Abt-530 Administered for 12 Weeks in Non-Cirrhotic Patients With Genotypes 4, 5, or 6 Infection (Surveyor-I)
err2016-04-01
err2
PREAI
errGane, Edward; Lalezari, Jacob; Asatryan, Armen; Greenbloom, Susan; Hassanein, Tarek I.; Ng, Teresa; Liu, Ran; Lin, Chih-Wei; Kort, Jens; Mensa, Federico
err分享
err收藏
NVR 3-778, A FIRST-IN-CLASS HBVCORE INHIBITOR, ALONE AND IN COMBINATION WITH PEG-INTERFERON (PEGIFN), IN TREATMENT-NAIVE HBEAG-POSITIVE PATIENTS: EARLY REDUCTIONS IN HBV DNA AND HBEAG
err2016-01-01
err45
PREAI
errYuen, M-F.; Kim, D. J.; Weilert, F.; Chan, H. L-Y.; Lalezari, J. P.; Hwang, S. G.; Nguyen, T.; Liaw, S.; Brown, N.; Klumpp, K.; Flores, O.; Hartman, G.; Gane, E.
err分享
err收藏